1 Table of Contents

• 1.1 List of Tables
• 1.2 List of Figures

2 Introduction

• 2.1 MRI (Magnetic Resonance Imaging) Coils Overview

3 Products under Development

• 3.1 MRI (Magnetic Resonance Imaging) Coils - Pipeline Products by Stage of Development
• 3.2 MRI (Magnetic Resonance Imaging) Coils - Pipeline Products by Territory
• 3.3 MRI (Magnetic Resonance Imaging) Coils - Pipeline Products by Regulatory Path
• 3.4 MRI (Magnetic Resonance Imaging) Coils - Pipeline Products by Estimated Approval Date

4 MRI (Magnetic Resonance Imaging) Coils - Pipeline Products under Development by Companies

• 4.1 MRI (Magnetic Resonance Imaging) Coils Companies - Pipeline Products by Stage of Development
• 4.2 MRI (Magnetic Resonance Imaging) Coils - Pipeline Products by Stage of Development

5 MRI (Magnetic Resonance Imaging) Coils Companies and Product Overview

• 5.1 BioMers Products LLC (Inactive) Company Overview
• 5.2 GE Healthcare LLC Company Overview
• 5.3 InkSpace Imaging Inc Company Overview
• 5.4 InsightMRI Company Overview
• 5.5 Institute of Cancer Research Company Overview
• 5.6 Medical College of Wisconsin Company Overview
• 5.7 New York University Company Overview
• 5.8 NorthShore University Health System Company Overview
• 5.9 Philips Healthcare Company Overview
• 5.10 ScanMed Medical Company Overview
• 5.11 Siemens Healthineers AG Company Overview
• 5.12 Time Medical, Inc. Company Overview
• 5.13 University of California Berkeley Company Overview
• 5.14 University of Minnesota Company Overview
• 5.15 University of North Carolina at Chapel Hill Company Overview
• 5.16 Worcester Polytechnic Institute Company Overview

6 MRI (Magnetic Resonance Imaging) Coils- Recent Developments

• 6.1 Mar 18, 2019: Bruker highlights new systems and applied market solutions at Pittcon
• 6.2 Mar 12, 2019: InkSpace Imaging names Peter Fischer as CEO
• 6.3 Mar 04, 2019: Bruker expands pharma and industrial NMR, EPR and software solutions
• 6.4 Feb 25, 2019: Nano4Imaging officially opened
• 6.5 Feb 11, 2019: Bruker reports fourth quarter and fiscal year 2018 financial results
• 6.6 Jan 16, 2019: James Borzi named Vice President, Global Supply Chain (CSCO) for GE Healthcare
• 6.7 Jan 07, 2019: Hologic preliminary revenues increase approximately 5% to $831 million in first quarter of fiscal 2019
• 6.8 Dec 10, 2018: Insightec announces expansion of executive management team
• 6.9 Nov 27, 2018: GE Healthcare to open biotechnology manufacturing center in UK
• 6.10 Nov 19, 2018: Hologic names Ludwig N. Hantson as Board Director
• 6.11 Nov 13, 2018: Elbit Imaging announces that the CMS has updated the reimbursment code for Insightec's MrgFUS treatments
• 6.12 Oct 31, 2018: Esaote ambassador of Italian excellence in Shanghai
• 6.13 Oct 01, 2018: INSIGHTEC''s MR-guided focused ultrasound treatment for essential tremor now covered by medicare in 25 states
• 6.14 Aug 08, 2018: Researchers Developed Effective MR Coil for Preclinical Studies
• 6.15 Aug 02, 2018: Bruker announces second quarter 2018 financial results
• 6.16 Aug 01, 2018: US judge finds Fujifilm infringed on Hologic’s mammography patents
• 6.17 Aug 01, 2018: Jay Ireland to Retire From GE; Farid Fezoua to Become Africa CEO
• 6.18 Jul 31, 2018: Hologic Announces Chief Financial Officer Change
• 6.19 Jul 31, 2018: Hologic Announces Financial Results for Third Quarter of Fiscal 2018
• 6.20 Jul 25, 2018: Jeffrey H. Barnes succeeds Iain Burns as President & CEO of Philips Canada
• 6.21 Jul 04, 2018: GE, Lagos State Government sign agreement on power, healthcare, skills development
• 6.22 Jul 03, 2018: INSIGHTEC''s MR-Guided Focused Ultrasound Treatment for Essential Tremor Now Covered by Medicare in Six Additional States
• 6.23 Jun 29, 2018: Todd Ernst Named GE’s Vice President of Investor Relations
• 6.24 Jun 20, 2018: Insightec's MRgFUS Earns Positive Nice Guidance For Treatment Of Essential Tremor
• 6.25 Jun 12, 2018: IMRIS Continues to Expand Global Customer Service
• 6.26 Jun 06, 2018: Bruker Names Gerald Herman As Chief Financial Officer
• 6.27 Jun 06, 2018: Bruker Corporation Appoints Gerald Herman as Chief Financial Officer
• 6.28 Jun 04, 2018: INSIGHTEC''s MR-Guided Focused Ultrasound Treatment for Essential Tremor Now Covered by Medicare
• 6.29 May 03, 2018: Bruker Reports First Quarter 2018 Financial Results
• 6.30 May 02, 2018: Hologic Announces Financial Results for Second Quarter of Fiscal 2018
• 6.31 Apr 26, 2018: Bruker Appoints Falko Busse as President of the Bruker BioSpin Group

7 Appendix

• 7.1 Methodology
• 7.2 About GlobalData
• 7.3 Contact Us

MRI (Magnetic Resonance Imaging) Coils - Medical Devices Pipeline Assessment, 2019

Summary

GlobalData's Medical Devices sector report, “MRI (Magnetic Resonance Imaging) Coils - Medical Devices Pipeline Assessment, 2019" provides an overview of MRI (Magnetic Resonance Imaging) Coils currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key MRI (Magnetic Resonance Imaging) Coils pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the MRI (Magnetic Resonance Imaging) Coils under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of MRI (Magnetic Resonance Imaging) Coils and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry.

Reasons to buy

The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of MRI (Magnetic Resonance Imaging) Coils under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date.